Android app on Google Play

Auxilium Pharmaceuticals, Inc. (AUXL) Tops Q4 EPS by 11c; Guides FY13

February 26, 2013 7:05 AM EST Send to a Friend
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) reported Q4 EPS of $1.83, $0.11 better than the analyst estimate of $1.72. Revenue for the quarter came in at $172.5 million versus the consensus estimate of $171.2 million.

Sees FY2013 revenue of $325-355 million, versus the consensus of $342.30 million. Net income on a non-GAAP basis will be in the range of $18 to $23 million.

For earnings history and earnings-related data on Auxilium Pharmaceuticals, Inc. (AUXL) click here.




You May Also Be Interested In


Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment